ALS (FRA:CP4) Common Stock: €1,033 Mil (As of Mar. 2026)


FRA:CP4 ALS Ltd FRA:CP4
88 GF Score
Price €13.80
GF Value €11.20
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is ALS Common Stock?

ALS FRA:CP4 +2.22% 88 Common Stock is €1,033 Mil as of Mar. 2026. GuruFocus rates FRA:CP4 with a GF Score™ of 88/100 and a GF Value™ of €11.20 (Modestly Overvalued). The stock has 1 warning sign investors should review.

ALS's quarterly common stock increased from Mar. 2025 (€780 Mil) to Sep. 2025 (€958 Mil) and increased from Sep. 2025 (€958 Mil) to Mar. 2026 (€1,033 Mil).

ALS's annual common stock declined from Mar. 2024 (€800 Mil) to Mar. 2025 (€780 Mil) but then increased from Mar. 2025 (€780 Mil) to Mar. 2026 (€1,033 Mil).

ALS Common Stock Historical Data

* Premium members only.

The historical data trend for ALS's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ALS Common Stock Chart

ALS Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 884.56 826.82 799.89 779.52 1,032.90

ALS Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 799.89 812.91 779.52 958.11 1,032.90
FRA:CP4
88GF Score
ALS Ltd FRA:CP4
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ALS Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €1,033 Mil mean?
ALS (FRA:CP4) has a Common Stock of €1,033 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on ALS and its competitors.
Is ALS's Common Stock too high?
ALS's current Common Stock is €1,033 Mil. Overall, ALS has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ALS's Common Stock compare to VRSK and EFX?
ALS's Common Stock of €1,033 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Business Services company?
A good Common Stock depends on the Business Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on ALS and its competitors. ALS's current Common Stock is €1,033 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ALS stock overvalued right now?
Based on GuruFocus' analysis, ALS (FRA:CP4) is currently considered Modestly Overvalued. The stock's GF Value™ is €11.20, compared to a current price of €13.80 — trading 23.2% above its estimated fair value. The current Common Stock is €1,033 Mil. ALS's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For ALS (FRA:CP4), the current Common Stock is €1,033 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ALS (FRA:CP4) Overvalued in 2026?

Based on GuruFocus' analysis, ALS stock appears to be overvalued. The current stock price of €13.80 is trading 23.2% above its estimated GF Value™ of €11.20. GuruFocus considers ALS to be Modestly Overvalued.

Key valuation signals for FRA:CP4:

  • Common Stock: €1,033 Mil
  • GF Value™: €11.20 vs. price of €13.80 (23.2% above fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the FRA:CP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ALS Business Description

Other Exchanges CPBLF:USAALQ:Australia
Address 25 King Street, Level 9B, Bowen Hills, Brisbane, QLD, AUS, 4006
Founded in the 1880s and listed on the ASX in 1952, ALS operates two divisions: commodities and life sciences. ALS commodities traditionally generated the majority of underlying earnings, providing geochemistry, metallurgy, inspection, and mine site services for the global mining industry. Expansion into environmental, pharmaceutical, and food testing areas has lessened earnings exposure to commodities.
88GF Score

Get the complete analysis for FRA:CP4

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.80
Price
€11.20
GF Value